It was reported that absence of glucagon signaling was associated with decreased body weight and food intake in GCGR knockout (Gcgr−/−) mice when HFD was challenged [24], implying a protective role of glucagon antagonists as anti-obesity agents. The gene discussed is GCGR; the disease is obesity disorder.